Author:
Kwan I. S.,Wilkinson D.,Cutajar D.,Lerch M.,Rosenfeld A.,Howie A.,Bucci J.,Chin Y.,Perevertaylo V. L.
Reference46 articles.
1. Permanent prostate brachytherapy: The significance of postimplant dosimetry;Lee;Rev. Urolo.,2004
2. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC);Cox;Int. J. Radiat. Oncol., Biol., Phys.,1995
3. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of Grade 2 or worse rectal bleeding;Akimoto;Int. J. Radiat. Oncol., Biol., Phys.,2006
4. What is the α∕β ratio for prostate cancer? Rationale for hypofractionated HDR brachytherapy;Duchesne;Int. J. Radiat. Oncol., Biol., Phys.,1999
5. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report;Martinez;Int. J. Radiat. Oncol., Biol., Phys.,2001
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献